Jason Boer

1.5k citations
12 papers · 1.0k indexed · h-index 9
Topics
Pharmacogenetics and Drug Metabolism (4 papers)Cancer Mechanisms and Therapy (2 papers)Drug Transport and Resistance Mechanisms (2 papers)

In The Last Decade

Jason Boer

12 papers receiving 966 citations

Peers

Jason Boer
Comparison fields: 5 of 86
  • Molecular Biology 406
  • Pharmacology 304
  • Organic Chemistry 188
  • Oncology 169
  • Computational Theory and Mathematics 158
Replace Ping Kang with:
Ping Kang United States
Yang Sai China
Stephen Fowler Switzerland
Satoru Asahi Japan
Cindy Q. Xia United States
Haoliang Yuan China
Ken Grime United Kingdom
Benny Amore United States
David B. Duignan United States
Jason Boer relative to Ping Kang United States Ping Kang's profile →
Citations per field
00.5×1.5×
Ping Kang · 1×
Citations per year

Countries citing papers authored by Jason Boer

Since Specialization
Citations

This map shows the geographic impact of Jason Boer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason Boer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason Boer more than expected).

Fields of papers citing papers by Jason Boer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jason Boer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason Boer. The network helps show where Jason Boer may publish in the future.

Co-authorship network of co-authors of Jason Boer

This figure shows the co-authorship network connecting the top 25 collaborators of Jason Boer. A scholar is included among the top collaborators of Jason Boer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jason Boer. Jason Boer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
#WorkIndexed citations
1 1
2 70
3 12
4 2
5 85
6 190
7 106
8 75
9
The complexities inherent in attempts to decrease drug clearance by blocking sites of CYP-mediated metabolism.
15
10 435
11 5
12 9

About Jason Boer

Jason Boer is a scholar working on Pharmacology, Pharmaceutical Science and Genetics, having authored 12 papers that have together received 1.0k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (4 papers), Cancer Mechanisms and Therapy (2 papers) and Drug Transport and Resistance Mechanisms (2 papers). The work is most often cited by research in Pharmacology (304 citations), Hepatology (122 citations) and Computational Theory and Mathematics (158 citations). Jason Boer has collaborated with scholars based in United States, Netherlands and Finland. Frequent co-authors include Kirk R. Henne, Sharon Diamond, Abdul Mutlib, Deepak Dalvie, Iain Gardner, Yasuhiro Nakai, John P. O’Donnell, R. Scott Obach, Shawn Harriman and Christopher L. Shaffer. Their work appears in journals such as Cancer Research, Clinical Cancer Research and Experimental Cell Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026